Anti-Phospholipase A2 Receptor (PLA2R) Antibody, IgG by ELISA
Also known as: ANTI-PLA2R
Use
This test is useful for diagnosing primary membranous nephropathy (PMN) and distinguishing it from secondary nephrotic syndrome. The semiquantitative measurement of PLA2R antibody levels by ELISA is suggested for monitoring response over time in individuals undergoing treatment for membranous nephropathy. A positive PLA2R antibody result, in conjunction with clinical symptoms and other laboratory findings, is suggestive of primary membranous nephropathy.
Special Instructions
Not provided.
Limitations
A positive anti-PLA2R antibody result suggests primary membranous nephropathy but the absence of circulating antibodies does not rule out the diagnosis. Antibody titers are useful for assessing disease severity and monitoring clinical remission; low antibody titers are associated with disease remission, while high titers indicate loss of kidney function and may necessitate a more aggressive therapeutic approach.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
Anti-Phospholipase A2 Receptor, IgG
Protein
LOINC Codes
- 73737-9 - PLA2R IgG Ser IA-aCnc
Result Turnaround Time
1-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated.
Causes for Rejection
Contaminated, heat-inactivated, grossly hemolyzed, grossly icteric, or grossly lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 2 weeks |
Other tests from different labs that may be relevant